These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2100245

  • 21. Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria.
    Emami S, Shafiee A, Foroumadi A.
    Mini Rev Med Chem; 2006 Apr; 6(4):375-86. PubMed ID: 16613574
    [Abstract] [Full Text] [Related]

  • 22. The fluorinated quinolones.
    Kidwai M, Misra P, Kumar R.
    Curr Pharm Des; 1998 Apr; 4(2):101-18. PubMed ID: 10197035
    [Abstract] [Full Text] [Related]

  • 23. Pharmacodynamics of quinolones.
    Dalhoff A.
    Drugs; 1995 Apr; 49 Suppl 2():197-9. PubMed ID: 8549302
    [No Abstract] [Full Text] [Related]

  • 24. Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens.
    Zerva L, Marshall SA, Jones RN.
    J Antimicrob Chemother; 1996 Oct; 38(4):742-4. PubMed ID: 8937972
    [No Abstract] [Full Text] [Related]

  • 25. Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
    Cho N, Miyakawa Z, Kimura T, Shimizu A, Notake Y, Kunii K.
    Drugs; 1995 Oct; 49 Suppl 2():391-2. PubMed ID: 8549373
    [No Abstract] [Full Text] [Related]

  • 26. Potent non-6-fluoro-substituted quinolone antibacterials: synthesis and biological activity.
    Ledoussal B, Bouzard D, Coroneos E.
    J Med Chem; 1992 Jan; 35(1):198-200. PubMed ID: 1732530
    [No Abstract] [Full Text] [Related]

  • 27. Lomefloxacin disc susceptibility criteria--a reappraisal.
    Smith JM, Hashmi ZS.
    J Antimicrob Chemother; 1990 Jul; 26(1):152-3. PubMed ID: 2211438
    [No Abstract] [Full Text] [Related]

  • 28. Syntheses and biological activities of new N1-aryl substituted quinolone antibacterials.
    Jürgens J, Schedletzky H, Heisig P, Seydel JK, Wiedemann B, Holzgrabe U.
    Arch Pharm (Weinheim); 1996 Apr; 329(4):179-90. PubMed ID: 8669982
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility.
    Schmitz FJ, Milatovic D, Boos M, Mayer S, Fluit AC.
    J Antimicrob Chemother; 2002 Apr; 49(4):698-701. PubMed ID: 11909849
    [No Abstract] [Full Text] [Related]

  • 30. Impact of fluoroquinolones on the gastrointestinal flora.
    Murray BE.
    Rev Infect Dis; 1989 Apr; 11 Suppl 5():S1372-8. PubMed ID: 2672259
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of new quinolones against anaerobic bacteria.
    Nord CE, Lindmark A, Persson I.
    Drugs; 1995 Apr; 49 Suppl 2():233-4. PubMed ID: 8549314
    [No Abstract] [Full Text] [Related]

  • 32. Anti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniques.
    Gozalbes R, Brun-Pascaud M, Garcia-Domenech R, Galvez J, Girard PM, Doucet JP, Derouin F.
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2771-6. PubMed ID: 10991859
    [Abstract] [Full Text] [Related]

  • 33. [Fluoroquinolones in antimicrobial therapy and prophylaxis in surgery].
    Vyhnánek F, Lochmann O.
    Rozhl Chir; 1995 Sep; 74(6):257-61. PubMed ID: 8658272
    [Abstract] [Full Text] [Related]

  • 34. [New fluoroquinolones and treatment of acute sinusitis].
    Gehanno P, Trémolières F.
    Presse Med; 1999 Sep 04; 28(25):1365. PubMed ID: 10506868
    [No Abstract] [Full Text] [Related]

  • 35. Impact of chemical structure on quinolone potency, spectrum and side effects.
    Percival A.
    J Antimicrob Chemother; 1991 Dec 04; 28 Suppl C():1-8. PubMed ID: 1787126
    [Abstract] [Full Text] [Related]

  • 36. In-vitro activity of the quinolone, PD 127,391.
    Shah PM.
    J Antimicrob Chemother; 1989 Oct 04; 24(4):617. PubMed ID: 2613608
    [No Abstract] [Full Text] [Related]

  • 37. [Latest news on fluoroquinolones].
    Bergogne-Bérézin E.
    Presse Med; 2002 Nov 30; 31(38):1805-6. PubMed ID: 12497722
    [Abstract] [Full Text] [Related]

  • 38. Intracellular penetration and bactericidal activity of the novel des-fluoro(6) quinolone, BMS-284756.
    Kolek B, Warr G, Bonner D, Fung-Tomc J.
    J Antimicrob Chemother; 2001 Sep 30; 48(3):445-6. PubMed ID: 11533015
    [No Abstract] [Full Text] [Related]

  • 39. The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment.
    Lewin CS, Morrissey I, Smith JT.
    Eur J Clin Microbiol Infect Dis; 1991 Apr 30; 10(4):240-8. PubMed ID: 1713846
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.